biomerieux-finance.com
BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/biofire-submits-de-novo-application-fda-filmarrayr-meningitisencephalitis-panel
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. BioFire Submits De Novo Application to FDA for FilmArray Meningitis/Encephalitis Panel. BioFire Submits De Novo Application to FDA for FilmArray Meningitis/Encephalitis Panel. Marcy l’Etoile, France. April 14, 2015 bioMérieux, a world leader in the field of. Diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a.
biomerieux-finance.com
Crossing of Thresholds | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/crossing-thresholds
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Article 10 of bioMérieux’s bylaws requires individuals or legal entities, acting alone or in concert, who directly or indirectly own 1% of the Company’s capital or voting rights, and thereafter for each additional 1%, to report. We have i...
biomerieux-finance.com
Ownership | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/ownership
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. BioMérieux Corporate Webportal site. Food and Biopharma Applications. Job Offers and Applications. Local Offices and Websites. Local Offices and Websites * *. 2014 bioMérieux SA. Last Update: March 10, 2014. You are about to enter the bioMérieux US site. The information contained in this site is specific for the US. Enter the US site. Don't ask me again.
biomerieux.fr
Notre Entreprise | bioMérieux France
http://www.biomerieux.fr/servlet/srt/bio/france/dynPage?node=Notre_societe
Skip to main content. BioMérieux dans le Monde. Découvrez tous nos sites. Europe, Moyen-Orient, Afrique. Afrique du Sud (Site Internet). Nouvelle Zélande (Site Internet). Be Smart With Resistance. Management de la Performance. Cardiologie - Insuffisance Cardiaque. Cardiologie - Syndrome Coronarien Aigu. Infections de la femme enceinte. Infections du Système Nerveux. Liste des Produits (A-M). Liste des Produits (N-Z). Air - Eau - Surface. Dénombrement des indicateurs de qualité. Laboratoire de Biologie Mé...
biomerieux-finance.com
Dividends | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/dividends
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Dividends that remain unclaimed five years after their payment date are time-barred and remitted to the French government. The Annual General Meeting held on May 26, 2016 approved a dividend of 1.00 per share, representing a total of 39.5 million paid in June 2016. Dividends per share for the past five years:. Dividends paid in Euros. 39,453,740.00.
biomerieux-finance.com
Shareholder's rights | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/shareholders-rights
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Every shareholder has right. BioMérieux Corporate Webportal site. Food and Biopharma Applications. Job Offers and Applications. Local Offices and Websites. Local Offices and Websites * *. 2014 bioMérieux SA. Last Update: March 10, 2014.
biomerieux.com
Médiathèque | bioMérieux Corporate Website
http://www.biomerieux.com/fr/mediatheque
Aller au contenu principal. Europe, Moyen-Orient, Afrique. Afrique du Sud (Site Internet). Nouvelle Zélande (Site Internet). Be Smart With Resistance. Gouvernement d’entreprise / Comité de direction. BioMérieux dans le monde. Audit Interne and Risques. Le contrôle microbiologique industriel. BioMérieux et le diagnostic. Médecine d’urgence et maladies cardiovasculaires. Applications biopharmaceutiques et cosmétiques. Nos technologies and systèmes. Services d’optimisation de la performance. 1 - Annecy, Fra...
biomerieux-finance.com
Analyst Coverage | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/analyst-coverage
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Hugo Solvet / Eric Leberrigaud. Exane BNP Paribas :. Anastasia Karpova / Mark Pospisilik. William R. Quirk. BioMérieux Corporate Webportal site. Food and Biopharma Applications. Job Offers and Applications. Local Offices and Websites. Local Offices and Websites * *. 2014 bioMérieux SA. Last Update: March 10, 2014. Enter the US site. Go to Canadian site.
biomerieux-finance.com
Being a Shareholder | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/being-shareholder
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. Service aux Emetteurs Les Grands Moulins de Pantin 9 Rue du débarcadère 93761 Pantin Cedex France. Shares are deposited with the financial intermediary of the shareholder’s choice. The shareholder has to contact his financial intermed...
biomerieux-finance.com
bioMérieux - First-Quarter 2015 Business Review | bioMérieux Investor Relations website
http://www.biomerieux-finance.com/content/biomerieux-first-quarter-2015-business-review-0
BioMérieux Investor Relations website. Welcome to the Shareholder Area. General Shareholders' Meeting. Participating in the General Shareholders' Meeting. BioMérieux - First-Quarter 2015 Business Review. BioMérieux - First-Quarter 2015 Business Review. Strong growth in sales. 448 million in sales. Up 208% as reported. Up 87% at constant exchange rates and scope of consolidation. Sales off to a fast start in the Americas, up 19.6%*. Strengthened positions in priority areas for growth. Enter the US site.
SOCIAL ENGAGEMENT